Advertisement
Research Article| Volume 2, ISSUE 1, P47-50, 1992

Evaluation of medical therapies of acute ischemic stroke

DOI:https://doi.org/10.1016/S1052-3057(10)80036-9
Evaluation of medical therapies of acute ischemic stroke
Previous ArticleStroke risk factors and stroke prevention
Next ArticlePros and cons of intensive care units for acute stroke
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Wiebers DO
        • Adams HP
        • Whisnant JP
        Animal models of stroke: are they relevant to human disease?.
        Stroke. 1989; 21: 1-3
        • Zivin JA
        • Grotta JC
        Animal stroke models. They are relevant to human disease.
        Stroke. 1990; 21: 981-983
        • Broderick JP
        • Phillips SJ
        • Whisnant JP
        • et al.
        Incidence rate of stroke in the eighties: the end of the decline of stroke?.
        Stroke. 1989; 20: 577-588
        • Astrup J
        • Sjesjo BK
        • Lymen L
        Thresholds in cerebral ischemia. The ischemic penumbra.
        Stroke. 1981; 12: 723-725
        • Weinstein PR
        • Anderson GG
        • Telles DA
        Neurological deficit and cerebral infarction after temporary middle cerebral artery occlusion in unanesthetized cat.
        Stroke. 1980; 17: 318-324
        • Caplan LR
        • Stein RW
        Stroke. A clinical approach. Butterworths, Boston1986
        • GISSI
        Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report.
        Lancet. 1987; 1: 871-874
        • Fieschi C
        • Argentino C
        • Lenzi GL
        • et al.
        Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours.
        J Neurol Sci. 1989; 91: 311-322
        • Mohr JR
        • Caplan LR
        • Melski JW
        • et al.
        The Harvard Cooperative Stroke Registry: a prospective registry.
        Neurology. 1978; 28: 754-762
        • Lhermitte F
        • Gautier JC
        • Derouesn C
        • et al.
        Ischemicaccidents in the middle cerebral artery territory. A study of the causes in 122 cases.
        Arch Neurol. 1968; 19: 248-256
        • Lenzi GLL
        • Frackowiack RSJ
        • Jones T
        • et al.
        Cerebral oxygen metabolism and blood flow in human cerebral ischemic infarction.
        J Cereb Blood Flow Metab. 1982; 2: 321-335
        • Wise RJS
        • Bernardi S
        • Frackowiak RSJ
        • et al.
        Serial observation on the pathophysiology of acute stroke.
        Brain. 1983; 106: 197-220
        • Holmes RA
        • Chaplin SB
        • Rayston SG
        • et al.
        Cerebral uptake and retention of Tc99m hexametylpropileneamine (Tc99m HM-PAO).
        Nucl Med Commun. 1985; 6: 443-447
        • Giubilei F
        • Lenzi GL
        • DiPiero V
        • et al.
        Predictive value of brain perfusion single-photon emission computed tomography in acute ischemic stroke.
        Stroke. 1990; 21: 895-900
        • Italian Acute Stroke Study Group
        Hemodilution in acute stroke: results of the Italian hemodilution trial.
        Lancet. 1988; 1: 318-320
        • Argentino C
        • Sacchetti ML
        • Toni D
        • et al.
        GM1 ganglioside therapy in acute ischemic stroke.
        Stroke. 1989; 20: 1143-1150

      17. Carolei A, Fieschi C, Sancesario G, et al. Early Stroke Trial (EST): a multicenter study on acute stroke patients. In: Proceedings of the World Federation of Neurology, 15th International Salzburg Conference, in press.

        • Frei A
        • Cottier C
        Glycerol and dextran combined in the therapy of acute stroke. A placebo-controlled double-blind trial with a planned interim analysis.
        Stroke. 1987; 18: 373-379
        • Hsu CY
        • Faught RE
        • Furlan AJ
        • et al.
        Intravenous prostacyclin in acute nonhemorrhagic stroke: a placebo-controlled double-blind trial.
        Stroke. 1987; 18: 352-358
        • Norris JW
        • Hachinski VC
        High-dose steroid treatment in cerebral infarction.
        Br Med J. 1986; 292: 21-23
        • Bayer AJ
        • Pathy MSJ
        • Newcombe R
        Double-blind, randomized trial of intravenous glycerol in acute stroke.
        Lancet. 1987; 1: 405-408
        • Gelmers HJ
        • Gorter K
        • De Werdt CJ
        • Wiezer HJA
        A controlled trial of nimodipine in acute ischemic stroke.
        N Engl J Med. 1988; 318: 203-207
        • Scandinavian Stroke Study Group (SSSG)
        Multicenter trial of hemodilution in acute ischemic stroke. Results of subgroup analysis.
        Stroke. 1988; 19: 464-471
        • Hsu CY
        • Norris JW
        • Hogan EL
        • et al.
        Pentoxifylline in acute nonhemorrhagic stroke.
        Stroke. 1988; 19: 716-719
        • Oczkowsky WJ
        • Hachinski VC
        • Bogousslavsky J
        • et al.
        A double-blind, randomized trial of PY108-68 in acute ischemic cerebral infarction.
        Stroke. 1989; 20: 604-608
        • Tazaky Y
        • Sakay F
        • Otomo E
        • et al.
        Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study.
        Stroke. 1988; 19: 221-226
        • Grotta JC
        • Pettigrew LC
        • Yatsu FM
        • et al.
        Hypervolemic hemodilution treatment of acute stroke.
        Stroke. 1989; 20: 317-323
        • DelZoppo G
        • Ferbert A
        • Otis S
        • et al.
        Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study.
        Stroke. 1988; 19: 307-313
        • Zeumer H
        • Freitag JH
        • Grzyska U
        • et al.
        Local intraarterial fibrinolysis in acute vertebrobasilar occlusion. Technical developments and recent results.
        Neuroradiology. 1989; 31: 336-340
        • Hacke W
        • Zeumer H
        • Ferbert A
        • et al.
        Intraarterial fibrinolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease.
        Stroke. 1988; 19: 1216-1222
        • Siesjo BK
        Cell damage in the brain. A speculative synthesis.
        J Cereb Blood Flow Metab. 1981; 1: 155-185
        • Nagaski K
        • Kasai M
        Channel selectivity and gating specificity of calcium-induced calcium-release channel in isolated sarcoplasmic reticulum.
        J Biochem. 1984; 96: 1769-1775
        • Kostyuk PG
        Diversity of calcium channels in cellular membranes.
        Neuroscience. 1989; 28: 253-261
        • Greenberg JH
        • Reivich M
        • Urbanics R
        • et al.
        The effect of GM1 on cerebral metabolism, microcirculation and histology in focal ischemia.
        in: Tettamanti G Ledeen RW Sadhoff K Gangliosides and neuronal plasticity. Liviana Press, Padova1986: 397-405
        • Mohr JP
        • Dijanni M
        • Muschett JL
        • et al.
        Associates Nimodipine Study Group: nimodipine in acute ischemic stroke.
        Ann Neurol. 1989; 26: 124
        • Rosenbaum D
        • Zabramski J
        • Frey J
        • et al.
        Early treatment of ischemic stroke with a calcium antagonist.
        Stroke. 1991; 22: 437-441

      Article info

      Identification

      DOI: https://doi.org/10.1016/S1052-3057(10)80036-9

      Copyright

      © 1992 National Stroke Association. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX